Clinical Trials on Mixed Dyslipidemias

Total 3952 results

Merck Sharp & Dohme LLC

Terminated

MK0354 Clinical Efficacy and Tolerability Study (0354-004)

Dyslipidemia
Merck Sharp & Dohme LLC

Terminated

Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)

Dyslipidemia
University of Alberta
AstraZeneca

Completed

A Community Based Approach to Dyslipidemia Management: Pharmacist Prescribing to Achieve Cholesterol Targets (RxACT)

Dyslipidemias

Canada
Merck Sharp & Dohme LLC

Completed

A Study of the Kinetics of a 13C-Cholesterol Infusate in Healthy Male Subjects (0000-108)(COMPLETED)

Dyslipidemia
Merck Sharp & Dohme LLC

Withdrawn

Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)

Dyslipidemia
Maastricht University Medical Center
DSM Nutritional Products, Inc.

Completed

Resveratrol and Serum Apo A-I

Dyslipidemia

Netherlands
AstraZeneca
Fundació Institut Català de Farmacologia

Withdrawn

Observational Study To Evaluate Statins Patterns Of Use In Spain

Dyslipidemia

Spain
Catabasis Pharmaceuticals

Completed

A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003

Dyslipidemia

United States
Akros Pharma Inc.

Completed

Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Dyslipidemia

United States
UCSF Benioff Children's Hospital Oakland
Dairy Management Inc.

Completed

Effect of Saturated Fat on Large Low-density Lipoprotein (LDL) and High-density Lipoprotein (HDL)

Dyslipidemia

United States
Bristol-Myers Squibb

Completed

Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia

Dyslipidemia

United States, Canada
MaiHealth Inc

Unknown

Longitudinal Study of Multi-Analyte Profile for Dyslipidemia

Dyslipidemia

United States
Indonesia University

Completed

Effect of Nigella Sativa on Lipid Profiles in Elderly

Dyslipidemia

Indonesia
AstraZeneca

Completed

Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients

Dyslipidemia

Mexico
Enzymotec

Completed

Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels

Dyslipidemia

Israel
AstraZeneca

Completed

Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea (CRESENDO)

Dyslipidemia

Korea, Republic of
Hospital de Clinicas de Porto Alegre

Completed

Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period

Dyslipidemia

Brazil
CHU de Quebec-Universite Laval
AstraZeneca

Completed

Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia

Dyslipidemia

Canada
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Safety and Pharmacokinetics of CKD-331

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348

Hypertension and Dyslipidemia

Korea, Republic of
Vital Signs Solutions Ltd

Recruiting

PocDoc Lipids Out-of-Surgery Study

Dyslipidemias

United Kingdom
Assiut University

Not yet recruiting

Assessment of Epicardial Fat Thickness in Children With Familial Dyslipidemia

Dyslipidemia
Daewoong Pharmaceutical Co. LTD.

Recruiting

A Study to Evaluate the Efficacy and Safety of CREZET Tablet

Dyslipidemias

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.

Recruiting

Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506. (Atorf-YOOrct)

Dyslipidemias

Korea, Republic of
Kowa Company, Ltd.

Completed

A Phase III Confirmatory Study of K-877 Extended Release Tablet

Dyslipidemias

Japan
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)

Dyslipidemias

Korea, Republic of
University of Leipzig
Charite University, Berlin, Germany; University of Jena; University Hospital...

Active, not recruiting

Statin-Intolerance Registry (SIR)

Dyslipidemias

Germany
Kowa Research Institute, Inc.

Completed

Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR

Dyslipidemia

United States
AstraZeneca

Completed

A Study of AZD8233 in Participants With Dyslipidemia. (HAYATE)

Dyslipidemia

Japan
Hanmi Pharmaceutical Company Limited

Completed

An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia

Dyslipidemia

Korea, Republic of
Organon and Co

Withdrawn

A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406) (VYCTORY)

Dyslipidemia
Sang Yeoup Lee

Completed

Ulmus Macrocarpa Hance Extract and Lipid Profile

Dyslipidemias

Korea, Republic of
Eli Lilly and Company

Completed

A Study of LY3475766 in Healthy Participants

Dyslipidemias

United States
Kowa Company, Ltd.

Completed

A Clinical Pharmacology Study of K-877 Controlled Release Tablet

Dyslipidemias

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study (AT GOAL)

Dyslipidemias

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol

Dyslipidemias

Belgium
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand

Dyslipidemias

Thailand
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol (LA ATGOAL)

Dyslipidemias

Brazil, Colombia, Panama, Mexico, Guatemala, Chile, Ecuador, Venezuela
University of Sorocaba

Completed

Effects of Lentinula Edodes Bars on Dyslipidemia and Oxidative Stress in Cholesterol Individuals: Randomized Study

Dyslipidemias

Brazil
Yonsei University

Completed

Effects of Pitavastatin Treatments on the Plasma Lgi3 Level in the Patients With Dyslipidemia

Dyslipidemias

Korea, Republic of
Hoffmann-La Roche

Completed

A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)

Dyslipidemia

United States
Daewon Pharmaceutical Co., Ltd.

Unknown

Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy

Dyslipidemias

Korea, Republic of
Kuhnil Pharmaceutical Co., Ltd.

Completed

Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled

Dyslipidemias
National Research Council, Spain

Completed

Cardiometabolic Response to a Sodium-bicarbonated Mineral Water

Dyslipidemia
Ajinomoto Foods Europe SAS
Naturalpha; Institut Polytechnique LaSalle Beauvais

Completed

Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidaemia (LLAX)

Dyslipidemias

France
Novartis

Completed

Fluvastatin in Adults With Dislipidemia With History of Muscle Problems

Dyslipidemia

Germany, United States
University of Miami
Humana Inc.

Completed

Improving Adherence to Statins Among Minority Populations

Dyslipidemia

United States

3

Subscribe